Structured PICO summaries for doctors and healthcare professionals, covering population, intervention, comparison, outcomes, expert commentary, and references across diabetes, endocrinology, obesity, and cardiometabolic medicine.
A phase-3 secondary analysis finds enavogliflozin lowers leptin independent of weight in type 2 diabetes, while the adiponectin rise was weight-dependent. PICO summary and commentary.
The 4-year DAPAHEART follow-up finds dapagliflozin raises coronary flow reserve by 34% and reduces epicardial fat, apparently independent of weight loss. PICO summary and commentary.
An RCT finds triple therapy with a statin, SGLT2 inhibitor, and PCSK9 inhibitor lowers lipids more than monotherapy in ischemic heart disease. PICO summary and commentary.
A cross-sectional study finds ultra-processed food intake is not linked to glucose or body size in type 2 diabetes, but is associated with higher LDL cholesterol. PICO summary and commentary.
A pilot crossover study finds single- and multi-joint resistance exercise both lower glucose acutely in type 2 diabetes, but neither beats a no-exercise control. PICO summary and commentary.
An RCT finds a medical Internet-of-Things lifestyle model lowers fasting glucose and reduces adverse pregnancy outcomes in gestational diabetes. PICO summary and commentary.
A crossover study finds protein raises GLP-1 longer while carbohydrate drives a bigger insulin and GIP response, with protein increasing nitrogen excretion. PICO summary and commentary.
An RCT finds an eight-session lifestyle health-promotion programme improves health behaviours and beliefs in type 2 diabetes, on self-report measures. PICO summary and commentary.
Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.
© 2024-2026 Hormone Insight. All rights reserved.
